Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E27.04 EPS (ttm)1.68 Insider Own0.21% Shs Outstand1.49B Perf Week-0.68%
Market Cap67.75B Forward P/E19.02 EPS next Y2.39 Insider Trans-1.13% Shs Float1.49B Perf Month1.47%
Income2.54B PEG2.66 EPS next Q0.61 Inst Own70.70% Short Float1.06% Perf Quarter-0.73%
Sales20.51B P/S3.30 EPS this Y-10.30% Inst Trans0.49% Short Ratio2.15 Perf Half Y-6.20%
Book/sh14.12 P/B3.22 EPS next Y10.76% ROA10.70% Target Price50.97 Perf Year4.82%
Cash/sh4.12 P/C11.04 EPS next 5Y10.18% ROE20.80% 52W Range38.77 - 51.44 Perf YTD3.03%
Dividend0.96 P/FCF83.75 EPS past 5Y-21.10% ROI6.20% 52W High-11.71% Beta0.86
Dividend %2.11% Quick Ratio1.50 Sales past 5Y-8.00% Gross Margin57.00% 52W Low17.14% ATR0.73
Employees77000 Current Ratio1.80 Sales Q/Q1.40% Oper. Margin14.00% RSI (14)59.24 Volatility1.14% 1.55%
OptionableYes Debt/Eq0.37 EPS Q/Q37.90% Profit Margin22.20% Rel Volume0.23 Prev Close45.41
ShortableYes LT Debt/Eq0.28 EarningsOct 21 BMO Payout31.70% Avg Volume7.32M Price45.42
Recom2.00 SMA200.43% SMA505.28% SMA200-1.87% Volume1,678,028 Change0.02%
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jul-18-13Reiterated Barclays Equal Weight $35 → $37
May-28-13Reiterated RBC Capital Mkts Outperform $38 → $42
May-21-13Initiated Gabelli & Co Buy
Apr-19-13Reiterated RBC Capital Mkts Outperform $37 → $38
Nov-26-15 01:21PM  Chilean businessman Bilbao fined $3.2 million for insider trading Reuters
Nov-25-15 06:30PM  Is Abbott Laboratories (ABT) A Good Stock To Buy? at Insider Monkey
Nov-24-15 11:30AM  The runaway inversion craze, in three charts at CNBC
10:47AM  Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016 at 24/7 Wall St.
Nov-23-15 01:30PM  Year-end market leaders: Pros
01:30PM  How secure are America's markets from attack?
08:09AM  3 Health Care Stocks to Buy Now for Decades of Dividends at TheStreet
Nov-22-15 02:54PM  5 Huge Stocks to Trade for Huge Gains at TheStreet
Nov-18-15 10:22AM  Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says
Nov-13-15 01:04PM  ABBOTT LABORATORIES Financials
12:33PM  TIMELINE-Mylan fails in $26 bln takeover bid for Perrigo Reuters
10:05AM  Abbott Laboratories (ABT) Stock Downgraded at Goldman Sachs at TheStreet
09:56AM  Goldman Is Downgrading Abbott Laboratories
Nov-12-15 03:39PM  IHI Moves into the Red as Market Witnesses Weakness
Nov-08-15 12:44PM  5 Trade ideas for Monday: Abbott Labs, Capital One, FedEX, ARM Holdings and Nuance
Nov-05-15 02:41PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report
Nov-04-15 06:22PM  Mallinckrodt Helps Pharmaceutical Subgroup of XLV to Outperform
Nov-03-15 07:57AM  [$$] Zoetis Lifts Outlook as Results Top Views at The Wall Street Journal
Nov-02-15 04:25PM  What's in the Cards for Zoetis (ZTS) this Earnings Season?
08:51AM  One thing Ackmans right about drug companies survive billions in fines at MarketWatch
Oct-30-15 12:31PM  Health is a Marathon, not a Sprint PR Newswire
Oct-29-15 03:52PM  'Science' Says Abbott Is a Top Employer PR Newswire
Oct-23-15 03:32PM  Chilean in $13.2 mln insider trading accord with U.S. regulators Reuters
10:07AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : October 23, 2015
10:03AM  Heres what CEOs said on this weeks earnings calls
08:35AM  4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now at 24/7 Wall St.
Oct-22-15 04:06PM  Health-Care Firestorm Engulfs Hospitals, AbbVie at
10:38AM  Abbott Laboratories Earnings Q3, 2015
10:10AM  Company News for October 22, 2015
08:01AM  Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire Young People to Donate Blood PR Newswire
08:01AM  Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire Young People to Donate Blood CNW Group
08:01AM  Abbott Teams Up with Football Star Cristiano Ronaldo to Inspire Young People to Donate Blood PR Newswire
Oct-21-15 01:52PM  Edited Transcript of ABT earnings conference call or presentation 21-Oct-15 1:00pm GMT
01:11PM  Abbott Labs (ABT) Stock Advancing on Earnings Beat, Analyst Note at TheStreet
12:16PM  Abbott (ABT) Posts Higher-Than-Expected Q3 Earnings
09:54AM  Abbott Gains On Q3 Beat, Emerging Market Growth Shines at
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:39AM  Abbott Labs (ABT) Tops Earnings in Q3
08:35AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:26AM  Biogen raises guidance, but Abbott narrows
08:22AM  Abbott sales beat as demand for generic drugs rises
07:57AM  Abbott Third-Quarter Profit Tops Estimates as Generic Sales Rise at Bloomberg
07:55AM  Abbott beats 3Q profit forecasts
07:52AM  Generic drug sales drive Abbott revenue
07:45AM  Abbott Reports Third-Quarter 2015 Results PR Newswire
07:07AM  Q3 2015 Abbott Laboratories Earnings Release - Before Market Open
Oct-20-15 06:53PM  Earnings may be just good enough for stocks at CNBC
03:17PM  Abbott Laboratories (ABT) Stock Lower Ahead of Wednesday's Earnings Report at TheStreet
Oct-19-15 02:50PM  Will Currency Hit Abbott Laboratories (ABT) in Q3 Earnings?
Oct-15-15 10:00AM  New York Road Runners and Abbott Partner for 2015 TCS New York City Marathon PR Newswire
Oct-14-15 03:55PM  Abbott Labs Releases Data on Dissolving Heart Stent Absorb
02:06PM  The Real Story Behind Biotech's Plunge and How to Profit at TheStreet
Oct-13-15 05:30PM  A Dissolving Heart Stent Works, But Is It Any Better For Patients? at Forbes
Oct-12-15 09:32PM  Abbotts Dissolving Stent Shows Mixed Results in Study at The Wall Street Journal
03:52PM  Abbott Laboratories Dissolving Stent Shows Mixed Results at The Wall Street Journal
02:25PM  Abbott Announces Positive Clinical Results of Absorb, the Naturally Dissolving Heart Stent PR Newswire
01:40PM  Apple's breakdown temporary: Halftime traders at CNBC
Oct-09-15 02:10PM  Boston Scientific Funds MValve to Boost TMVR Expansion
06:30AM  Abbott Labs Is a Healthy Candidate for the 'Buying Dividends' Strategy at TheStreet
Oct-07-15 03:16PM  Kentucky pharmacy PharMerica agrees to $9.25M settlement
02:35PM  PharMerica to pay $9.25 million to settle kickback allegations at
12:23PM  Retail upgrade bolsters Lululemon shares at Financial Times
10:16AM  Abbott (ABT) Stock Rises on Barclays Upgrade at TheStreet
09:50AM  Illinois Fortune 500 corporations keeping nearly $136B overseas to avoid taxes: study at
08:41AM  Analysts' Actions -- Tesla, Abbott, Morgan Stanley, Yum at TheStreet
08:28AM  Barclays Upgrades Abbott, Sees 'Selling Overdone'
Oct-06-15 05:05PM  Boston Scientific's Bioabsorbable Stent Wins FDA Approval
04:30PM  Valeant Shares Down 37% since August; More Pain Ahead?
Oct-05-15 10:26AM  Put Alcoa's Spinoff on Your Watch List at Forbes
Oct-01-15 05:46PM  Celsion Begins Patient Enrollment in Ovarian Cancer Study
03:16PM  Drugmaker Tactic to Block Generics May Violate Law, FTC Says at Bloomberg
01:00PM  Abbott Celebrates Living Fully Through the Power of Health as an Official Sponsor of the 2015 Bank of America Chicago Marathon PR Newswire
Sep-30-15 05:35PM  Roche Presents Positive Data on Respiratory Drug Esbriet
03:08PM  Johnson & Johnsons Pharmaceuticals Segment Grows in 2Q15
09:10AM  2 Deutsche Bank Health Care Focus Stocks Have Big Upside Potential at 24/7 Wall St.
09:00AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
Sep-28-15 05:01PM  The 8 Top Business Incubators at Investopedia
Sep-24-15 08:40AM  10 Stocks That Even the Pope Could Love at Kiplinger
Sep-22-15 10:00AM  What Does It Mean to Live Fully? PR Newswire
08:00AM  Abbott Marks 15 Years of Helping Career-Minded Moms Reach Their Full Professional Potential PR Newswire
Sep-18-15 05:30PM  Sanofi, Pfizer Said to Express Interest in Buying Mexico's Rimsa
02:41PM  Neurocrine crushes the IBB
Sep-17-15 09:00AM  Abbott Declares 367th Consecutive Quarterly Dividend PR Newswire
Sep-16-15 11:10AM  TENX: Initiating Coverage of Tenax Therapeutics, Inc. - Targeting Critical Care with Levosimendan
08:00AM  New Technology Can Offer People with Cataracts a Full Range of Vision and Freedom from Eyeglasses CNW Group
Sep-15-15 01:52AM  Malcolm Turnbull Is Sworn In as Australias New Prime Minister at The Wall Street Journal
Sep-14-15 10:48AM  Turnbull to become Australian PM after Liberals reject Abbott at Financial Times
Sep-11-15 08:00AM  Why Wall Street loves to hate Mylans CEO at Fortune
Sep-10-15 12:47PM  Abbott Named Industry Leader for Responsible and Sustainable Business for Three Consecutive Years on the Dow Jones Sustainability Index (DJSI) PR Newswire
Sep-08-15 06:02AM  How Rock Health Went From Accelerator To Venture Fund In Five Years at Forbes
Sep-02-15 09:00AM  Abbott Completes Acquisition of Tendyne Holdings, Inc. PR Newswire
Sep-01-15 04:00AM  Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study PR Newswire
Aug-31-15 07:15AM  10 Dividend Stocks You Should Have Bought Wednesday at TheStreet
05:47AM  Traders turn fast money in Abbott
Aug-28-15 04:54PM  The Top 3 Medtech Buyout Rumors This Week at Investor's Business Daily
Aug-27-15 12:41PM  Cramer Remains Cautious on Stocks at TheStreet
11:25AM  Abbott & St. Jude NO deal talk; Williams-Sonoma drops outlook; SolarCity upgraded
11:19AM  Stocks Extend Highs as S&P 500, Dow Recover From Correction at TheStreet
10:25AM  St. Jude Medical, Inc. (STJ) Shares Rally Following Mistaken Report Of Acquisition Bid From Abbott Laboratories (ABT) at Insider Monkey
10:21AM  Drugmaker Abbott says not pursuing an offer for St Jude Medical
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices to treat vascular diseases. Abbott Laboratories also offers blood, continuous, and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes under the FreeStyle brand; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM
Fussell Stephen RExecutive Vice PresidentAug 18Sale50.4613,096660,854130,601Aug 20 05:18 PM
Fussell Stephen RExecutive Vice PresidentAug 11Option Exercise21.2241,500880,605172,101Aug 13 05:02 PM
Funck Robert EVice President, ControllerJul 29Option Exercise21.2226,000551,70497,448Jul 30 05:51 PM
Blaser Brian JExecutive Vice PresidentJul 28Sale50.9611,300575,904102,194Jul 30 05:52 PM
Pavee Jean-YvesSenior Vice PresidentJun 03Option Exercise25.9810,500272,77536,106Jun 05 06:05 PM
Pavee Jean-YvesSenior Vice PresidentJun 03Sale49.0010,500514,50025,606Jun 05 06:05 PM
BIRD ROGERSenior Vice PresidentApr 27Option Exercise23.0124,348560,22366,358Apr 29 06:23 PM
Mason Heather LExecutive Vice PresidentApr 27Sale47.4513,500640,599121,489Apr 29 06:24 PM
BIRD ROGERSenior Vice PresidentApr 27Sale47.5728,5481,357,88937,810Apr 29 06:23 PM
Contreras JaimeSenior Vice PresidentMar 31Sale46.4322810,5862,094Apr 02 05:03 PM
White J. ScottSenior Vice PresidentMar 26Option Exercise22.4918,600418,364108,202Mar 27 05:10 PM
White J. ScottSenior Vice PresidentMar 26Sale46.6812,483582,66395,719Mar 27 05:10 PM
Warmuth Michael JExecutive Vice PresidentMar 10Sale46.4113,500626,58149,433Mar 12 05:32 PM
Contreras JaimeSenior Vice PresidentMar 02Sale47.349,209435,95436,898Mar 03 05:20 PM
Pavee Jean-YvesSenior Vice PresidentMar 02Sale47.4865230,95825,606Mar 03 05:07 PM
Contreras JaimeSenior Vice PresidentFeb 18Sale46.2642319,5681,379Feb 18 05:49 PM
Simhambhatla Murthy VSenior Vice PresidentFeb 17Sale46.411727,98345,199Feb 19 05:11 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 17Sale46.381727,97851,941Feb 19 05:12 PM
Pavee Jean-YvesSenior Vice PresidentFeb 17Sale46.4162128,82122,912Feb 18 06:45 PM
Funck Robert EVice President, ControllerFeb 13Option Exercise22.2710,542234,73973,468Feb 17 05:55 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Option Exercise25.2583,0002,095,426309,945Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.7638,7731,774,430236,880Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.839,935455,340226,945Feb 06 05:12 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.6634,2921,565,612275,653Feb 06 05:11 PM